A phase II study of active immunotherapy with PANVAC or autologous, cultured dendritic cells infected with PANVAC after complete resection of hepatic metastases of colorectal carcinoma.

A phase II study of active immunotherapy with PANVAC or autologous, cultured dendritic cells infected with PANVAC after complete resection of hepatic metastases of colorectal carcinoma. Clin Colorectal Cancer. 2006 Jan; 5(5):368-71.

View in: PubMed

subject areas

Adenocarcinoma
Cancer Vaccines
Clinical Trials, Phase II as Topic
Colorectal Neoplasms
Dendritic Cells
Humans
Immunotherapy, Active
Liver Neoplasms
Randomized Controlled Trials as Topic
Vaccines, Synthetic

authors with profiles

David J. Cole